What is the Effect of Pseudoexfoliation Syndrome on Renal Function in Patients without Glaucoma?

dc.authorscopusid34869701000
dc.authorscopusid26655524000
dc.authorscopusid23968920100
dc.contributor.authorGönen, Tansu
dc.contributor.authorGönen, Korcan Aysun
dc.contributor.authorGüzel, Savaş
dc.date.accessioned2022-05-11T14:10:15Z
dc.date.available2022-05-11T14:10:15Z
dc.date.issued2014
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Göz Hastalıkları Ana Bilim Dalı
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyoloji Ana Bilim Dalı
dc.departmentFakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Biyokimya Ana Bilim Dalı
dc.description.abstractPurpose: To evaluate renal function in patients with pseudoexfoliation syndrome. Materials and Methods: This prospective, cross-sectional, case-control study involved 49 patients with pseudoexfoliation syndrome (PEX) and 42 control subjects. Renal function was examined by biochemical parameters and Doppler ultrasonography. Serum creatinine, blood urea nitrogen, urea levels, urine microalbumin level and creatinine clearance were measured. Renal volume, resistive index and pulsatility index were calculated using Doppler ultrasonography. Results: The mean laboratory values for both groups were as follows: Creatinine, PEX: 0.81 +/- 0.28 mg/dL - Control: 0.79 +/- 0.22 mg/dL; urea, PEX: 31.6 +/- 9.7 mg/dL - Control: 32.2 +/- 8.4 mg/dL; blood urea nitrogen, PEX: 14.8 +/- 4.6 mg/dL - Control: 15.1 +/- 4.0 mg/dL; creatinine clearance, PEX: 89.1 +/- 35.6 mL/min - Control: 99.0 +/- 47.2 mL/min; microalbumin, PEX: 5.8 +/- 22.7 mg/dL - Control: 2.7 +/- 6.0 mg/dL. The differences between groups were not significant (p > 0.300). Renal volume, resistive index and pulsatility index values were similar in both groups (p > 0.200). Conclusions: This study showed that pseudoexfoliation syndrome does not affect biochemical and ultrasonographic parameters associated with renal function.
dc.identifier.doi10.3109/02713683.2013.834940
dc.identifier.endpage193
dc.identifier.issn0271-3683
dc.identifier.issn1460-2202
dc.identifier.issue2en_US
dc.identifier.pmid24073722
dc.identifier.scopus2-s2.0-84893001271
dc.identifier.scopusqualityQ2
dc.identifier.startpage188
dc.identifier.urihttps://doi.org/10.3109/02713683.2013.834940
dc.identifier.urihttps://hdl.handle.net/20.500.11776/5343
dc.identifier.volume39
dc.identifier.wosWOS:000330070500009
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorGönen, Tansu
dc.institutionauthorGönen, Korcan Aysun
dc.institutionauthorGüzel, Savaş
dc.language.isoen
dc.publisherInforma Healthcare
dc.relation.ispartofCurrent Eye Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBiochemical parameters
dc.subjectblood-aqueous barrier
dc.subjectDoppler ultrasonography
dc.subjectglomerular filtration barrier
dc.subjectpseudoexfoliation syndrome
dc.subjectrenal function
dc.subjectBlood-Aqueous Barrier
dc.subjectResistive Index
dc.subjectExfoliation Syndrome
dc.subjectDoppler Sonography
dc.subjectPseudo-Exfoliation
dc.subjectRenovascular Resistance
dc.subjectParenchymal Disease
dc.subjectPulsatility Index
dc.subjectKidney-Disease
dc.subjectLens Capsule
dc.titleWhat is the Effect of Pseudoexfoliation Syndrome on Renal Function in Patients without Glaucoma?
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
5343.pdf
Boyut:
109.14 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text